Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?

PloS One
Yeona ChoJaeho Cho

Abstract

Treatment of the primary tumor reportedly improves survival in several types of metastatic cancer. We herein evaluated the efficacy and toxicity of radiotherapy for the primary tumor in prostate cancer with metastasis. The study cohort included 140 men with metastatic prostate cancer at initial diagnosis. Metastatic sites were divided into 4 groups as follows: solitary bone, 2-4 bones, ≥5 bones, and visceral organs. Patient, tumor, and treatment characteristics, and clinical outcomes were compared between patients treated with (prostate radiotherapy [PRT] group) or without radiotherapy to the primary tumor. Patients in PRT group presented with a statistically significantly younger age (p = .02), whereas other characteristics showed no significant difference. Overall survival (OS) and biochemical failure-free survival (BCFFS) were improved in PRT patients (3-year OS: 69% vs. 43%, p = 0.004; 3-year BCFFS: 52% vs. 16%, p = 0.002). Multivariate analysis identified PRT as a significant predictor of both OS (hazard ratio [HR] = 0.43, p = 0.015). None of the 38 PRT patients experienced severe (grade ≥3) genitourinary or gastrointestinal toxicity. Our data suggest that radiotherapy to the primary tumor was associated with improved OS a...Continue Reading

References

Oct 5, 2001·Lancet·G H MickischUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary Group
Jul 20, 2002·International Journal of Radiation Oncology, Biology, Physics·Michael J ZelefskySteven A Leibel
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John J CoenWilliam U Shipley
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Sandra DemariaSilvia C Formenti
Sep 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Larissa K F TempleDeborah Schrag
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Jan 13, 2006·The Journal of Urology·John S LamArie S Belldegrun
Mar 2, 2006·Journal of the National Cancer Institute·Mustafa AdliMehmet E Kalender
Mar 2, 2006·Journal of the National Cancer Institute·Palmira ForoJavier Sanz
May 17, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elisabetta RapitiChristine Bouchardy
Jun 27, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Dirk BoehmerUNKNOWN EORTC radiation oncology group
Mar 4, 2008·International Journal of Radiation Oncology, Biology, Physics·Michael J ZelefskyHoward I Amols
Dec 17, 2008·International Journal of Radiation Oncology, Biology, Physics·Ik Jae LeeJaeho Cho
Feb 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dorothea WeckermannChristoph A Klein
Oct 24, 2009·Brachytherapy·Samuel D McGrathLarry L Kestin
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
May 27, 2011·The New England Journal of Medicine·Johann S de BonoUNKNOWN COU-AA-301 Investigators
Jun 8, 2011·Nature Reviews. Clinical Oncology·Scott C Morgan, Chris C Parker
Feb 15, 2012·International Journal of Radiation Oncology, Biology, Physics·David H A NguyenMary Lesperance
Mar 9, 2012·The New England Journal of Medicine·Michael A PostowJedd D Wolchok
Apr 6, 2012·Annals of Surgical Oncology·David H A NguyenCheryl Alexander
Sep 8, 2012·Journal of the National Comprehensive Cancer Network : JNCCN·James L MohlerDorothy A Shead
Jul 25, 2014·Therapeutic Advances in Medical Oncology·Daniel L Suzman, Emmanuel S Antonarakis
Aug 12, 2014·European Urology·Giorgio GandagliaMaxine Sun

❮ Previous
Next ❯

Citations

Nov 3, 2016·Nature Reviews. Urology·Jeffrey J TosoianEdward M Schaeffer
Jun 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chad G RusthovenThomas J Pugh
Jul 18, 2017·International Journal of Molecular Sciences·Geoffrey BryantDavid J Mulholland
Mar 25, 2018·International Journal of Urology : Official Journal of the Japanese Urological Association·Derya TilkiChristopher P Evans
Nov 2, 2018·World Journal of Urology·Ken ChowChristopher M Hovens
Nov 13, 2019·Nature Reviews. Clinical Oncology·Martin J ConnorHashim U Ahmed
Sep 21, 2018·American Society of Clinical Oncology Educational Book·Andrew W HahnNeeraj Agarwal
May 15, 2018·Prostate Cancer·Pedro Leonel Almeida, Bruno Jorge Pereira
Nov 21, 2018·World Journal of Urology·Ye YuanNicholas G Nickols
Jun 27, 2020·World Journal of Urology·Jochen WalzGwenaelle Gravis
Apr 16, 2019·Frontiers in Immunology·Natasha VitkinMadhuri Koti
Aug 29, 2020·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·A LavilleI Latorzeff
Apr 4, 2018·Molecular Pharmaceutics·P Jack HoopesSteven N Fiering
Aug 20, 2021·Research and Reports in Urology·Kazuhiro WatanabeTsutomu Nishiyama

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.